Trademark: 88861225
Status Date
Monday, October 30, 2023
Filing Date
Monday, April 6, 2020
Published for Opposition
Tuesday, August 4, 2020
Abandoned Date
Monday, October 30, 2023
5 stem cells for medical purposes; therapeutic cell preparation for the treatment of auto-immune diseases, and inflammatory and immune disorders; therapeutic agents for the modulation of cells for use as immunotherapies
Oct 30, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Oct 30, 2023
Abandonment - No Use Statement Filed
Mar 8, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 7, 2023
Sou Extension 5 Granted
Feb 22, 2023
Sou Extension 5 Filed
Mar 7, 2023
Case Assigned To Intent To Use Paralegal
Feb 22, 2023
Sou Teas Extension Received
Sep 17, 2022
Notice Of Approval Of Extension Request E-Mailed
Sep 15, 2022
Sou Extension 4 Granted
Sep 15, 2022
Sou Extension 4 Filed
Sep 15, 2022
Sou Teas Extension Received
Mar 18, 2022
Notice Of Approval Of Extension Request E-Mailed
Mar 16, 2022
Sou Extension 3 Granted
Mar 16, 2022
Sou Extension 3 Filed
Mar 16, 2022
Sou Teas Extension Received
Sep 18, 2021
Notice Of Approval Of Extension Request E-Mailed
Sep 16, 2021
Sou Extension 2 Granted
Sep 16, 2021
Sou Extension 2 Filed
Sep 16, 2021
Sou Teas Extension Received
Mar 27, 2021
Notice Of Approval Of Extension Request E-Mailed
Mar 25, 2021
Sou Extension 1 Granted
Mar 25, 2021
Sou Extension 1 Filed
Mar 25, 2021
Sou Teas Extension Received
Sep 29, 2020
Noa E-Mailed - Sou Required From Applicant
Aug 4, 2020
Official Gazette Publication Confirmation E-Mailed
Aug 4, 2020
Published For Opposition
Jul 15, 2020
Notification Of Notice Of Publication E-Mailed
Jun 29, 2020
Approved For Pub - Principal Register
Jun 24, 2020
Assigned To Examiner
Apr 15, 2020
New Application Office Supplied Data Entered
Apr 9, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
